Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

(Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison

			%		No. of excluded cases					Included cases
Site	ICD-10	Total registered	HV	DCO	DCO	No. follow-up	Others	Total	%	No.	%
C01-02	Tongue	101	94.1	0.0	0	16	0	16	15.8	85	84.2
C03-06	Oral cavity	124	95.2	1.6	2	19	2	23	18.5	101	81.5
C09	Tonsil	59	98.3	0.0	0	7	1	8	13.6	51	86.4
C11	Nasopharynx	167	81.4	9.0	15	19	0	34	20.4	133	79.6
C12-13	Hypopharynx	78	94.9	0.0	0	9	0	9	11.5	69	88.5
C15	Oesophagus	109	75.2	0.9	1	20	0	21	19.3	88	80.7
C16	Stomach	408	77.7	2.2	9	82	1	92	22.5	316	77.5
C18	Colon	310	81.9	1.6	5	66	2	73	23.5	237	76.5
C19-20	Rectum	219	83.1	0.0	0	29	0	29	13.2	190	86.8
C22	Liver	993	42.5	12.0	119	168	1	288	29.0	705	71.0
C23-24	Gall bladder	182	62.1	1.6	3	44	0	47	25.8	135	74.2
C25	Pancreas	132	46.2	0.8	1	24	1	26	19.7	106	80.3
C26	Gastrointestinal tract unspecified	93	28.0	55.9	52	10	0	62	66.7	31	33.3
C30-31	Nose/Sinuses	39	76.9	0.0	0	6	0	6	15.4	33	84.6
C32	Larynx	184	83.2	1.6	3	28	0	31	16.8	153	83.2
C33-34	Lung	2135	61.4	10.4	223	267	3	493	23.1	1642	76.9
C40-41	Bone	45	64.4	15.6	7	3	0	10	22.2	35	77.8
C43	Melanoma skin	31	100.0	0.0	0	4	0	4	12.9	27	87.1
C44	Other skin	268	98.1	1.9	5	92	2	99	36.9	169	63.1
C47+C49	Connective tissue	53	100.0	0.0	0	8	0	8	15.1	45	84.9
C50	Breast	621	93.6	1.4	9	65	3	77	12.4	544	87.6
C51	Vulva	31	100.0	0.0	0	3	0	3	9.7	28	90.3
C53	Cervix	973	96.8	0.4	4	81	3	88	9.0	885	91.0
C54	Corpus uteri	125	86.4	8.8	11	16	0	27	21.6	98	78.4
C56	Ovary	197	88.8	0.5	1	33	1	35	17.8	162	82.2
C60	Penis	92	94.6	0.0	0	20	0	20	21.7	72	78.3
C61	Prostate	148	92.6	0.0	0	39	2	41	27.7	107	72.3
C64	Kidney	58	70.7	5.2	3	16	1	20	34.5	38	65.5
C67	Urinary bladder	273	87.5	0.4	1	48	1	50	18.3	223	81.7
C70-72	Brain & nervous system	103	68.0	13.6	14	13	1	28	27.2	75	72.8
C73	Thyroid	164	93.9	0.0	0	34	0	34	20.7	130	79.3
C81	Hodgkin lymphoma	42	100.0	0.0	0	12	0	12	28.6	30	71.4
C82-85+C96	Non-Hodgkin lymphoma	369	99.7	0.3	1	67	3	71	19.2	298	80.8
C91	Lymphoid leukaemia	76	100.0	0.0	0	6	0	6	7.9	70	92.1
C92-94	Myeloid leukaemia	135	100.0	0.0	0	13	0	13	9.6	122	90.4
C95	Leukaemia unspecified	64	75.0	25.0	16	4	1	21	32.8	43	67.2

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Chiang Mai, Thailand, 1993-1997)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1985-1992 and 1993-1997 (Chiang Mai, Thailand)
- Table6b:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1985-1992 and 1993-1997 (Chiang Mai, Thailand)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)